Symbol="XBIT"
AssetType="Common Stock"
Name="XBiotech Inc"
Description="XBiotech Inc., a biopharmaceutical company, discovers, develops and markets True Human monoclonal antibodies for the treatment of various diseases. The company is headquartered in Austin, Texas."
CIK="1626878"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="8201 E. RIVERSIDE DRIVE, BUILDING 4, SUITE 100, AUSTIN, TX, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="154936000"
EBITDA="-31443000"
PERatio="None"
PEGRatio="0"
BookValue="7.9"
DividendPerShare="0"
DividendYield="0"
EPS="-0.97"
RevenuePerShareTTM="0.132"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.0823"
ReturnOnEquityTTM="-0.125"
RevenueTTM="3510000"
GrossProfitTTM="3359000"
DilutedEPSTTM="-0.97"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.933"
AnalystTargetPrice="18"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="11.9"
PriceToBookRatio="0.405"
EVToRevenue="0.686"
EVToEBITDA="3.944"
Beta="1.213"
num_52WeekHigh="6.69"
num_52WeekLow="3"
num_50DayMovingAverage="5.47"
num_200DayMovingAverage="4.099"
SharesOutstanding="30439300"
DividendDate="2021-07-23"
ExDividendDate="2021-07-15"
symbol="XBIT"
open="5.15"
high="5.25"
low="5.06"
price="5.09"
volume="15059.00"
latest_trading_day="2023-08-11"
previous_close="5.08"
change="0.01"
change_percent="0.1969%"
aroon_positive_momentum_days="66"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="66"
Volume_recent_avg="65602"
Change_recent_avg="0.01"
Delta_recent_avg="0.3"
Variance_recent_avg="0.15"
Change_ratio_recent_avg="0.07"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_positive_60"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="66"
Aroon_momentum_negative="34"
image_negative_thumbnail_id_1="1126"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0159.jpeg"
image_negative_thumbnail_id_2="136"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0040.jpeg"
image_neutral_thumbnail_id_1="568"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0031.jpeg"
image_neutral_thumbnail_id_2="588"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0011.jpeg"
image_positive_thumbnail_id_1="988"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0150.jpeg"
image_positive_thumbnail_id_2="1008"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0170.jpeg"
image_professor_thumbnail_id_1="1175"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
image_professor_thumbnail_id_2="1193"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
